Journal
EMERGING INFECTIOUS DISEASES
Volume 26, Issue 7, Pages 1633-1635Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2607.201285
Keywords
-
Categories
Funding
- European Union's Horizon 2020 research and innovation program [871029]
- Pfizer
Ask authors/readers for more resources
Most reverse transcription PCR protocols for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include 2-3 targets for detection. We developed a triplex, real-time reverse transcription PCR for SARS-CoV-2 that maintained clinical performance compared with singleplex assays. This protocol could streamline detection and decrease reagent use during current high SARS-CoV-2 testing demands.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available